At a glance
- Originator Nonindustrial source
- Class Nonsteroidal anti-inflammatories; Small molecules
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 20 Aug 1996 No-Development-Reported for Rheumatic disorders (Unknown route)